Business

CardioComm HeartCheck(TM) Wireless, Wearable 12 Lead ECG and Holter Patch Solution for Remote and in Home ECG Monitoring Planned for 2021

Patient Self-Monitoring with ECG Triaging Services will Support Remote Monitoring Needs ...

articleCardiocomm Solutions, Inc.December 23, 20204/company/cardiocomm-solutions-inc/news/cardiocomm-heartchecktm-wireless-wearable-12-lead-ecg-and-holter-patch-solution-for-remote-and-in-home-ecg-monitoring-planned-for-2021
CardioComm HeartCheck(TM) Wireless, Wearable 12 Lead ECG and Holter Patch Solution for Remote and in Home ECG Monitoring Planned for 2021

About this update from Cardiocomm Solutions, Inc.

[{"type":"text","content":"CardioComm HeartCheck(TM) Wireless, Wearable 12 Lead ECG and Holter Patch Solution for Remote and in Home ECG Monitoring Planned for 2021Patient Self-Monitoring with ECG Triaging Services will Support Remote Monitoring NeedsTORONTO, ON / ACCESSWIRE / December 23, 2020 / CardioComm Solutions, Inc. (TSX VENTURE:EKG) (\"CardioComm\" or the \"Company\"), a global provider of consumer heart monitoring and electrocardiogram (\"ECG\") device and software solutions, confirms plans to develop a multi-lead, wireless, ECG patch device for use in clinics, skilled nursing facilities, clinical trials as well as to support remote patient monitoring (\"RPM\") and telehealth services and prescribed in-home arrhythmia monitoring.The wearable innovation is a result of a software/hardware partnership agreement with South Korea based Healthrian Co. Ltd. (\"Healthrian\"). The HeartCheck™ 12 lead/Holter/event ECG platform will include a compact, rechargeable and water proof ECG recorder, a self-placed disposable ECG patch with pre-alignment anatomical placement of electrodes, a smartphone mobile app and a HIPAA-compliant cloud-based ECG management solution that will support automated algorithm assisted, and manual reviews and reporting, of uploaded ECG recordings.CardioComm has already implemented a family of ECG management systems that can support one to 12 leads of ECG data of varying durations that are licensed under the Global ECG Management Solution (\"GEMS™\" ) and GlobalCardio™ product brands with Health Canada and the Food and Drug Administration (\"FDA\") Class II medical device clearances for the sale of over-the-counter and through prescription. Healthrian has developed a novel 12 lead ECG monitoring hardware solution using an ECG module that can connect via Bluetooth to a Smart device for the transfer of collected multi-channel ECG data. The module can use a number of different ECG electrode options including a patch or conventional ECG cables. Healthrian and CardioComm plan to integrate their respective technologies to bring multiple new medical and wellness devices to service the ambulatory ECG and arrhythmia monitoring markets globally.CardioComm will be the lead applicant for medical device clearances with the FDA and Health Canada and will leverage their cleared GEMS™ and GlobalCardio™ software techn...

More updates from Cardiocomm Solutions, Inc.